应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ONCY Oncolytics Biotech Inc
盘前交易 01-12 06:44:36 EST
0.9677
-0.0239
-2.41%
最高
1.01
最低
0.9600
成交量
69.43万
今开
0.9971
昨收
0.9916
日振幅
5.04%
总市值
1.05亿
流通市值
1.03亿
总股本
1.08亿
成交额
67.98万
换手率
0.65%
流通股本
1.06亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中表现出良好疗效的转化数据
美股速递 · 2025-12-16
Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中表现出良好疗效的转化数据
Oncolytics Biotech® 与FDA达成一致,确定Pelareorep在一线胰腺癌中的关键研究设计
美股速递 · 2025-11-19
Oncolytics Biotech® 与FDA达成一致,确定Pelareorep在一线胰腺癌中的关键研究设计
Oncolytics Biotech Inc:预计第二线或后期SCAC单臂研究的潜在启动日期在2026年上半年
美股速递 · 2025-10-28
Oncolytics Biotech Inc:预计第二线或后期SCAC单臂研究的潜在启动日期在2026年上半年
Oncolytics Biotech®公布最新的肛门癌数据,客观反应率超过当前治疗标准的两倍
美股速递 · 2025-10-28
Oncolytics Biotech®公布最新的肛门癌数据,客观反应率超过当前治疗标准的两倍
Oncolytics Biotech®提交 circular/prospectus以召开特别股东会议,拟将注册地更改至内华达州
美股速递 · 2025-10-20
Oncolytics Biotech®提交 circular/prospectus以召开特别股东会议,拟将注册地更改至内华达州
Oncolytics Biotech Inc.盘中异动 早盘大幅下跌5.17%
市场透视 · 2025-09-04
Oncolytics Biotech Inc.盘中异动 早盘大幅下跌5.17%
Oncolytics Biotech Inc.盘中异动 下午盘股价大跌7.70%
市场透视 · 2025-08-09
Oncolytics Biotech Inc.盘中异动 下午盘股价大跌7.70%
Oncolytics Biotech Inc.盘中异动 股价大跌5.26%报0.900美元
市场透视 · 2025-08-06
Oncolytics Biotech Inc.盘中异动 股价大跌5.26%报0.900美元
Oncolytics Biotech Inc.盘中异动 股价大跌6.35%
市场透视 · 2025-08-04
Oncolytics Biotech Inc.盘中异动 股价大跌6.35%
Oncolytics Biotech Inc.盘中异动 快速下跌5.86%报0.960美元
市场透视 · 2025-08-01
Oncolytics Biotech Inc.盘中异动 快速下跌5.86%报0.960美元
Oncolytics Biotech Inc.盘中异动 股价大跌5.05%
市场透视 · 2025-07-30
Oncolytics Biotech Inc.盘中异动 股价大跌5.05%
Oncolytics Biotech Inc.盘中异动 早盘大幅拉升5.60%
市场透视 · 2025-07-17
Oncolytics Biotech Inc.盘中异动 早盘大幅拉升5.60%
Oncolytics Biotech Inc.盘中异动 股价大跌5.00%
市场透视 · 2025-07-15
Oncolytics Biotech Inc.盘中异动 股价大跌5.00%
加拿大皇家银行:维持Oncolytics Biotech(ONCY.US)评级,由优于大市调整至优于大市评级, 目标价由6.00美元调整至5.00美元。
金融界 · 2025-03-11
加拿大皇家银行:维持Oncolytics Biotech(ONCY.US)评级,由优于大市调整至优于大市评级, 目标价由6.00美元调整至5.00美元。
Oncolytics Biotech Inc.盘中异动 早盘大幅下跌5.59%
市场透视 · 2025-03-10
Oncolytics Biotech Inc.盘中异动 早盘大幅下跌5.59%
Oncolytics Biotech 2024财年GAAP每股收益(C$0.41)优于预期(C$0.42),$1590万现金余量可支撑至2025年第三季度
财报速递 · 2025-03-07
Oncolytics Biotech 2024财年GAAP每股收益(C$0.41)优于预期(C$0.42),$1590万现金余量可支撑至2025年第三季度
Oncolytics Biotech Inc.盘中异动 早盘股价大跌5.12%报0.700美元
市场透视 · 2025-03-06
Oncolytics Biotech Inc.盘中异动 早盘股价大跌5.12%报0.700美元
Oncolytics Biotech Inc.盘中异动 快速拉升6.03%报0.689美元
市场透视 · 2025-03-06
Oncolytics Biotech Inc.盘中异动 快速拉升6.03%报0.689美元
Oncolytics Biotech Inc.盘中异动 早盘股价大跌6.49%
市场透视 · 2025-03-04
Oncolytics Biotech Inc.盘中异动 早盘股价大跌6.49%
Oncolytics Biotech Inc.盘中异动 快速跳水5.18%报0.717美元
市场透视 · 2025-02-20
Oncolytics Biotech Inc.盘中异动 快速跳水5.18%报0.717美元
加载更多
公司概况
公司名称:
Oncolytics Biotech Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Oncolytics Biotech Inc.于1998年4月2日根据亚伯达法律以亚伯达有限责任公司的名字成立。该公司是一家临床阶段的生物制药公司,开发pelareorep,这是一种安全且耐受性良好的静脉递送免疫治疗剂,可激活先天和适应性免疫系统并削弱肿瘤防御机制。这提高了免疫系统对抗癌症的能力,使肿瘤更容易受到广泛的肿瘤治疗。
发行价格:
--
{"stockData":{"symbol":"ONCY","market":"US","secType":"STK","nameCN":"Oncolytics Biotech Inc","latestPrice":0.9677,"timestamp":1767992400000,"preClose":0.9916,"halted":0,"volume":694279,"delay":0,"floatShares":106000000,"shares":108000000,"eps":-0.285545,"marketStatus":"盘前交易","change":-0.0239,"latestTime":"01-12 06:44:36 EST","open":0.9971,"high":1.01,"low":0.96,"amount":679787.383861,"amplitude":0.050424,"askPrice":1,"askSize":200,"bidPrice":0.967,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.285545,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768228200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1002254400000,"exchange":"NASDAQ","adjPreClose":0.9677,"postHourTrading":{"tag":"盘后","latestPrice":0.97,"preClose":0.9677,"latestTime":"19:34 EST","volume":7375,"amount":7140.0751,"timestamp":1768005273326},"volumeRatio":1.51157676795084},"requestUrl":"/m/hq/s/ONCY","defaultTab":"news","newsList":[{"id":"1124995891","title":"Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中表现出良好疗效的转化数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1124995891","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124995891?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:02","pubTimestamp":1765893759,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech® 发布支持 Pelareorep 在 KRAS 突变转移性结直肠癌中的良好疗效及转化数据的消息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"1144869574","title":"Oncolytics Biotech® 与FDA达成一致,确定Pelareorep在一线胰腺癌中的关键研究设计","url":"https://stock-news.laohu8.com/highlight/detail?id=1144869574","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144869574?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:02","pubTimestamp":1763560935,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech® 与FDA达成一致,确定Pelareorep在一线胰腺癌中的关键研究设计","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"1147095809","title":"Oncolytics Biotech Inc:预计第二线或后期SCAC单臂研究的潜在启动日期在2026年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1147095809","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147095809?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:32","pubTimestamp":1761651164,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech Inc:预计第二线或后期SCAC单臂研究的潜在启动日期在2026年上半年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"1106931199","title":"Oncolytics Biotech®公布最新的肛门癌数据,客观反应率超过当前治疗标准的两倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1106931199","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106931199?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:30","pubTimestamp":1761651014,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech®公布最新的肛门癌数据,客观反应率超过当前治疗标准的两倍","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"1199687209","title":"Oncolytics Biotech®提交 circular/prospectus以召开特别股东会议,拟将注册地更改至内华达州","url":"https://stock-news.laohu8.com/highlight/detail?id=1199687209","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199687209?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:02","pubTimestamp":1760965328,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech®提交 circular/prospectus以召开特别股东会议,拟将注册地更改至内华达州","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY","BK4139"],"gpt_icon":0},{"id":"2565533418","title":"Oncolytics Biotech Inc.盘中异动 早盘大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565533418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565533418?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:58","pubTimestamp":1756994304,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日21时58分,Oncolytics Biotech Inc.股票出现异动,股价急速下跌5.17%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.87%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、冠科美博、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Purple Biotech Ltd、Soligenix, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为1448.95%、129.37%、31.95%,振幅较大的相关个股有冠科美博、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为35.56%、30.93%、17.54%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904215824a4b41aaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904215824a4b41aaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCY","ONCWF","BK4139"],"gpt_icon":0},{"id":"2558571003","title":"Oncolytics Biotech Inc.盘中异动 下午盘股价大跌7.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558571003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558571003?lang=zh_cn&edition=full","pubTime":"2025-08-09 03:13","pubTimestamp":1754680393,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日03时13分,Oncolytics Biotech Inc.股票出现波动,股价快速下跌7.70%。截至发稿,该股报0.845美元/股,成交量77.3976万股,换手率0.80%,振幅8.74%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体跌幅为1.10%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809031313a47dbfda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809031313a47dbfda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCWF","ONCY"],"gpt_icon":0},{"id":"2557250306","title":"Oncolytics Biotech Inc.盘中异动 股价大跌5.26%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557250306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557250306?lang=zh_cn&edition=full","pubTime":"2025-08-06 23:47","pubTimestamp":1754495231,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日23时47分,Oncolytics Biotech Inc.股票出现异动,股价急速跳水5.26%。截至发稿,该股报0.900美元/股,成交量8.0068万股,换手率0.08%,振幅6.95%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806234711a6d6e634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806234711a6d6e634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCY","ONCWF","BK4139"],"gpt_icon":0},{"id":"2556387973","title":"Oncolytics Biotech Inc.盘中异动 股价大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556387973?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:48","pubTimestamp":1754315307,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时48分,Oncolytics Biotech Inc.股票出现异动,股价快速下跌6.35%。截至发稿,该股报0.927美元/股,成交量9.3245万股,换手率0.10%,振幅4.04%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、凯信远达涨幅较大,Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为4243.81%、1035.90%、448.73%,振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Soligenix, Inc.,振幅分别为64.62%、54.96%、33.03%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421482794ceef29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421482794ceef29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCY","ONCWF"],"gpt_icon":0},{"id":"2556146728","title":"Oncolytics Biotech Inc.盘中异动 快速下跌5.86%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556146728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556146728?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:34","pubTimestamp":1754055263,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时34分,Oncolytics Biotech Inc.股票出现异动,股价大幅下跌5.86%。截至发稿,该股报0.960美元/股,成交量6.932万股,换手率0.07%,振幅5.64%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,4D Molecular Therapeutics, Inc.、Bioxcel Therapeutics, Inc.、天境生物涨幅较大,Bioxcel Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Artelo Biosciences, Inc.较为活跃,换手率分别为796.12%、111.30%、75.52%,振幅较大的相关个股有Tiziana Life Sciences Ltd、Neurosense Therapeutics Ltd.、Jyong Biotech Ltd.,振幅分别为20.40%、14.12%、13.14%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213424a46fe20c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213424a46fe20c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCY","ONCWF","BK4139"],"gpt_icon":0},{"id":"2555638110","title":"Oncolytics Biotech Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555638110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555638110?lang=zh_cn&edition=full","pubTime":"2025-07-30 00:28","pubTimestamp":1753806531,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日00时28分,Oncolytics Biotech Inc.股票出现异动,股价急速下挫5.05%。截至发稿,该股报1.04美元/股,成交量150.837万股,换手率1.56%,振幅6.88%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300028519725c8e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300028519725c8e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCY","ONCWF"],"gpt_icon":0},{"id":"2552482568","title":"Oncolytics Biotech Inc.盘中异动 早盘大幅拉升5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482568?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:33","pubTimestamp":1752759208,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时33分,Oncolytics Biotech Inc.股票出现波动,股价急速拉升5.60%。截至发稿,该股报1.32美元/股,成交量9.809万股,换手率0.10%,振幅2.40%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Briacell Therapeutics Corp C/Wts 涨幅较大,Windtree Therapeutics, Inc.、Immuron Limited、Abpro Holdings, Inc较为活跃,换手率分别为423.61%、177.29%、105.45%,振幅较大的相关个股有Windtree Therapeutics, Inc.、知临集团、Jupiter Neurosciences, Inc.,振幅分别为35.56%、20.10%、15.80%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213328a451404c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213328a451404c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCWF","ONCY","BK4139"],"gpt_icon":0},{"id":"2551195355","title":"Oncolytics Biotech Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551195355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551195355?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:13","pubTimestamp":1752592425,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日23时13分,Oncolytics Biotech Inc.股票出现异动,股价急速跳水5.00%。截至发稿,该股报1.14美元/股,成交量24.1988万股,换手率0.25%,振幅4.99%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为1803.02%、1514.71%、1381.82%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.,振幅分别为416.92%、109.47%、75.50%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715231345a6ab7d32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715231345a6ab7d32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCWF","ONCY"],"gpt_icon":0},{"id":"2518700012","title":"加拿大皇家银行:维持Oncolytics Biotech(ONCY.US)评级,由优于大市调整至优于大市评级, 目标价由6.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518700012","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518700012?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:52","pubTimestamp":1741625543,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Oncolytics Biotech(ONCY.US)评级,由优于大市调整至优于大市评级, 目标价由6.00美元调整至5.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11005248641243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ONCY"],"gpt_icon":0},{"id":"2518713012","title":"Oncolytics Biotech Inc.盘中异动 早盘大幅下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518713012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518713012?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:52","pubTimestamp":1741614720,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时52分,Oncolytics Biotech Inc.股票出现波动,股价快速下挫5.59%。截至发稿,该股报0.650美元/股,成交量2.8965万股,换手率0.04%,振幅5.78%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2809.66%、628.56%、126.92%,振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、28.59%、25.35%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021520198a2a262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021520198a2a262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCWF","ONCY"],"gpt_icon":0},{"id":"1109304519","title":"Oncolytics Biotech 2024财年GAAP每股收益(C$0.41)优于预期(C$0.42),$1590万现金余量可支撑至2025年第三季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1109304519","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109304519?lang=zh_cn&edition=full","pubTime":"2025-03-07 20:12","pubTimestamp":1741349531,"startTime":"0","endTime":"0","summary":"Oncolytics Biotech 报告季度每股亏损$,优于分析师预期的$,超出2.38%。这与去年同期持平。以上内容来自Benzinga Earnings专栏,原文如下:Oncolytics Biotech reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.38 percent. This is unchanged from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Oncolytics Biotech 2024财年GAAP每股收益(C$0.41)优于预期(C$0.42),$1590万现金余量可支撑至2025年第三季度","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCY"],"gpt_icon":0},{"id":"2517660251","title":"Oncolytics Biotech Inc.盘中异动 早盘股价大跌5.12%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517660251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517660251?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:44","pubTimestamp":1741272275,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时44分,Oncolytics Biotech Inc.股票出现异动,股价大幅跳水5.12%。截至发稿,该股报0.700美元/股,成交量5.4394万股,换手率0.07%,振幅3.48%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃,换手率分别为1276.82%、263.37%、58.71%,振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为31.46%、30.53%、23.72%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224435abeb7b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224435abeb7b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCWF","ONCY","BK4139"],"gpt_icon":0},{"id":"2517940666","title":"Oncolytics Biotech Inc.盘中异动 快速拉升6.03%报0.689美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940666?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:51","pubTimestamp":1741197100,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时51分,Oncolytics Biotech Inc.股票出现波动,股价急速拉升6.03%。截至发稿,该股报0.689美元/股,成交量5.0539万股,换手率0.07%,振幅4.60%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为1.24%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为942.34%、304.49%、296.39%,振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.,振幅分别为82.59%、54.27%、47.22%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306015140989d727e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306015140989d727e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCWF","ONCY"],"gpt_icon":0},{"id":"2516677970","title":"Oncolytics Biotech Inc.盘中异动 早盘股价大跌6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677970?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098674,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分,Oncolytics Biotech Inc.股票出现波动,股价快速下挫6.49%。截至发稿,该股报0.620美元/股,成交量5.3039万股,换手率0.07%,振幅0.00%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Exicure, Inc.、Protagenic Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1047.69%、1024.96%、405.58%,振幅较大的相关个股有Orchestra Biomed Holdings, Inc.、Hoth Therapeutics, Inc.、Jasper Therapeutics, Inc.,振幅分别为5.85%、5.06%、4.84%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223114a25f03fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223114a25f03fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCY","BK4139","ONCWF"],"gpt_icon":0},{"id":"2512806814","title":"Oncolytics Biotech Inc.盘中异动 快速跳水5.18%报0.717美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512806814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512806814?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:36","pubTimestamp":1739986567,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时36分,Oncolytics Biotech Inc.股票出现异动,股价快速下跌5.18%。截至发稿,该股报0.717美元/股,成交量23.1895万股,换手率0.30%,振幅5.29%。Oncolytics Biotech Inc.股票所在的生物技术行业中,整体涨幅为0.45%。Oncolytics Biotech Inc.公司简介:Oncolytics Biotech Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220013607988b4f34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220013607988b4f34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCY","ONCWF","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncolyticsbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0221},{"period":"3month","weight":-0.1936},{"period":"6month","weight":-0.1799},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.1072}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oncolytics Biotech Inc.于1998年4月2日根据亚伯达法律以亚伯达有限责任公司的名字成立。该公司是一家临床阶段的生物制药公司,开发pelareorep,这是一种安全且耐受性良好的静脉递送免疫治疗剂,可激活先天和适应性免疫系统并削弱肿瘤防御机制。这提高了免疫系统对抗癌症的能力,使肿瘤更容易受到广泛的肿瘤治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.000116},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.050372},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.105719},{"month":4,"riseRate":0.714286,"avgChangeRate":0.022868},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.009291},{"month":6,"riseRate":0.285714,"avgChangeRate":0.190573},{"month":7,"riseRate":0.5,"avgChangeRate":0.009647},{"month":8,"riseRate":0.25,"avgChangeRate":-0.092405},{"month":9,"riseRate":0.125,"avgChangeRate":-0.025103},{"month":10,"riseRate":0.5,"avgChangeRate":0.144514},{"month":11,"riseRate":0.25,"avgChangeRate":0.020161},{"month":12,"riseRate":0.125,"avgChangeRate":0.270533}],"exchange":"NASDAQ","name":"Oncolytics Biotech Inc","nameEN":"Oncolytics Biotech Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oncolytics Biotech Inc(ONCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oncolytics Biotech Inc(ONCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oncolytics Biotech Inc,ONCY,Oncolytics Biotech Inc股票,Oncolytics Biotech Inc股票老虎,Oncolytics Biotech Inc股票老虎国际,Oncolytics Biotech Inc行情,Oncolytics Biotech Inc股票行情,Oncolytics Biotech Inc股价,Oncolytics Biotech Inc股市,Oncolytics Biotech Inc股票价格,Oncolytics Biotech Inc股票交易,Oncolytics Biotech Inc股票购买,Oncolytics Biotech Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oncolytics Biotech Inc(ONCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oncolytics Biotech Inc(ONCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}